Clinical Trials Browser

Phase EARLY_PHASE1 × Adenoviridae Infections × 90 days × Clear all

NCT07538128 2026-04-20

Evaluating Safety, Tolerability, and Preliminary Efficacy of YSCH-01 Monotherapy and in Combination With Atezolizumab for Recurrent Glioblastoma

Phase EARLY_PHASE1 Recruiting

Adenoviridae Infections, Glioblastoma